Cocrystal Pharma, Inc. (COCP) Tops Q3 EPS by 12c

Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q3 EPS of ($0.41), $0.12 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.

You May Also Be Interested In

• Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
• Piper Sandler Starts Arm Holdings (ARM) at Overweight
• Needham on Chewy Inc. (CHWY): 'Growth Concerns Remain'